Other · VGF-derived neuroendocrine peptide
Neuroendocrine regulatory peptide-2 (NERP-2)
Also known as NERP-2
A 38-residue VGF processing product used to explore vasopressin regulation and orexin-linked hypothalamic circuits.
- Length
- 38 amino acids
- Half-life
- Not well characterised
- Mechanism
- NERP-2 influences hypothalamic neuroendocrine signalling, including inhibition of stimulated vasopressin release in rodent preparations. Experimental evidence also links some of its actions to orexin-dependent circuitry, but a definitive direct receptor has not been established.
- Studied in
- NERP-2 is investigated in rodent hypothalamic preparations and animal models examining osmotic signalling, feeding behaviour and orexin-associated neuronal activity.
About Neuroendocrine regulatory peptide-2 (NERP-2)
NERP-2 is a 38-amino-acid product of the neuronal and endocrine secretory precursor VGF. It was described alongside NERP-1 in 2007 during investigations of endogenous peptides generated by precursor processing. The two peptides occupy distinct regions of VGF and should not be treated as interchangeable fragments. Sequence identity, species of origin and terminal chemistry are therefore important when matching a synthetic research reagent to a published experimental preparation.
Studies of NERP-2 encompass both vasopressin-associated neurosecretion and hypothalamic circuits involving orexin neurons. In rodent experiments, dependence on orexin signalling has been explored using genetic and pharmacological approaches. Such dependence indicates a circuit relationship, not proof that NERP-2 binds an orexin receptor. Because its primary receptor remains unresolved, mechanistic studies benefit from combining secretion measurements, neuronal activation markers and pathway-disruption experiments rather than relying on a single downstream endpoint.
Laboratory notes
- Verify sequence identity by mass spectrometry and review chromatographic purity before comparing NERP-2 with other VGF fragments.
- Assess peptide recovery in the selected assay buffer; adsorption to vessels can distort low-concentration secretion experiments.
- Include independent controls for orexin-pathway perturbation, since altered circuit activity does not demonstrate direct NERP-2 receptor binding.
Storage and reconstitution basics: storage guide.
Questions about Neuroendocrine regulatory peptide-2 (NERP-2)
Does NERP-2 directly activate orexin receptors?
Direct activation has not been established. Evidence for orexin-dependent effects concerns downstream circuitry and should not be presented as a confirmed receptor assignment.
Is NERP-2 an extended version of NERP-1?
No. They are separate processing products from different regions of the same VGF precursor.
Why combine secretion assays with neuronal measurements?
Secretion measurements reveal an output, whereas neuronal recordings or activation markers help localise the circuit response. Together they provide a more informative mechanistic picture.
Is Neuroendocrine regulatory peptide-2 (NERP-2) for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.